Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417863
Max Phase: Preclinical
Molecular Formula: C18H17ClN4O3S
Molecular Weight: 404.88
Molecule Type: Small molecule
Associated Items:
ID: ALA2417863
Max Phase: Preclinical
Molecular Formula: C18H17ClN4O3S
Molecular Weight: 404.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/C(=N\NC(=S)Nc1ccc(C(=O)NCC(=O)O)cc1)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C18H17ClN4O3S/c1-11(12-2-6-14(19)7-3-12)22-23-18(27)21-15-8-4-13(5-9-15)17(26)20-10-16(24)25/h2-9H,10H2,1H3,(H,20,26)(H,24,25)(H2,21,23,27)/b22-11+
Standard InChI Key: ACJOFTPGKJJXDP-SSDVNMTOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 404.88 | Molecular Weight (Monoisotopic): 404.0710 | AlogP: 2.87 | #Rotatable Bonds: 6 |
Polar Surface Area: 102.82 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.40 | CX Basic pKa: 1.42 | CX LogP: 2.79 | CX LogD: -0.50 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.34 | Np Likeness Score: -1.67 |
1. El-Sharief MA, Abbas SY, El-Bayouki KA, El-Bayouki KA, El-Gammal EW.. (2013) Synthesis of thiosemicarbazones derived from N-(4-hippuric acid)thiosemicarbazide and different carbonyl compounds as antimicrobial agents., 67 [PMID:23871906] [10.1016/j.ejmech.2013.06.031] |
Source(1):